The GLP-1 Supercycle: How the Next Generation of Blockbusters is Reshaping Medicine
From cardiovascular protection to cognitive decline, the race to dominate a projected $300 billion market moves far beyond weight loss as a wave of oral therapies and new mechanisms enter the fray.